Antifragile Supply Chain with Strategic Capacity Planning
Pharma companies must commit to major investments long before the future becomes clear. To improve strategic capacity planning, AstraZeneca moved beyond single forecasts and began testing decisions across thousands of possible scenarios. The result was a shift toward an antifragile supply chain that does more than survive volatility.